|
Football’s yellow card
becomes a call for action on
cardiovascular, renal, and
metabolic health at
Boehringer Ingelheim’s CRM
United event
(DUBAI)
-
Boehringer Ingelheim,
one of the world’s leading
research-driven
biopharmaceutical companies,
recently hosted its CRM
United awareness event on a
football pitch at RAD Sports
– Dubai Studio City. The
venue became the stage for
an inspiring afternoon
dedicated to raising
awareness about the
interconnectivity between
cardiovascular, renal, and
metabolic (CRM) diseases and
the importance of early
diagnosis.
With over
850 million people living
with chronic kidney disease,
589 million with diabetes,
and 64 million with heart
failure, the need for
awareness and action is more
pressing than ever. The
event brought together
Dr. Mona Alrukhaimi,
President of the Emirates
Medical Association for
Nephrology and
Transplantation; Dr. Nadya
Almatrooshi, General
Secretary and Head of Heart
Failure Working Group of the
Emirates Cardiac Society;
Dr. Mohamed Farghaly,
Scientific Committee
Chairperson of the Emirates
Family Medicine Society;
Boehringer Ingelheim
colleagues; and football
star Ahmed Fathy.
Drawing parallels between
teamwork on the pitch and
the body’s interconnected
CRM systems, the event
emphasized that – just like
in football – when one
player struggles, the whole
team feels the pressure.
At the heart of the
event stood a giant yellow
card, football’s universal
symbol of warning,
reimagined as a “Card of
Action.” Event attendees
wrote one-word commitments
such as Act, Protect,
Unite, and Defend in
response to the question
“How do you respond to a
warning?” This shared moment
transformed the yellow card
into a symbol of empowerment
– encouraging people to
recognize the warning signs
and potential complications
of CRM diseases, and act
early to protect their
overall health. The event
also featured friendly
football matches among
colleagues, reinforcing the
essence of teamwork,
collaboration, and shared
commitment to CRM health.
Reflecting on the
initiative, Evren
Ozlu, Head of Human Pharma
for the India, Middle East,
Turkey, and Africa (IMETA)
region, said, “CRM
United reflects our belief
that awareness helps improve
lives. By connecting science
with something people love –
football – we hope to
inspire earlier action and a
stronger understanding of
how interconnected CRM
health really is. Every step
towards awareness is a step
towards helping people live
better, healthier lives.”
By turning football’s
most recognizable warning
into a call for early
action, Boehringer
Ingelheim’s CRM United
reinforces the company’s
ongoing commitment to
raising public awareness,
empowering communities, and
inspiring people to act
early to protect their
health – because life has no
extra time.
References:
1. Marassi, M., & Fadini, G. P. (2023). The
cardio-renal-metabolic
connection: a review of the
evidence. Cardiovascular
diabetology, 22(1), 195.
https://doi.org/10.1186/s12933-023-01937-x
2. KDIGO
2022 Clinical Practice
Guideline for Diabetes
Management in Chronic Kidney Disease
(pdf)
3. Heart
failure and chronic kidney
disease manifestation and
mortality risk associations
in type 2 diabetes: A large
multinational cohort study -
PubMed
4. New
global kidney health report
sheds light on current
capacity around the world to
deliver kidney care -
International Society of
Nephrology
5. IDF
Diabetes Atlas 2025 | Global
Diabetes Data & Insights
6.
Global burden of heart
failure: a comprehensive and
updated review of
epidemiology - PubMed
PRINT
THIS ARTICLE
|
